Discovery, SAR, and Pharmacokinetics of a Novel 3-Hydroxyquinolin-2(1H)-one Series of Potent d-Amino Acid Oxidase (DAAO) Inhibitors
3-Hydroxyquinolin-2(1H)-one (2) was discovered by high throughput screening in a functional assay to be a potent inhibitor of human DAAO, and its binding affinity was confirmed in a Biacore assay. Cocrystallization of 2 with the human DAAO enzyme defined the binding site and guided the design of new analogues. The SAR, pharmacokinetics, brain exposure, and effects on cerebellum D-serine are described. Subsequent evaluation against the rat DAAO enzyme revealed a divergent SAR versus the human enzyme and may explain the high exposures of drug necessary to achieve significant changes in rat or mouse cerebellum D-serine.
- Research Organization:
- Argonne National Laboratory (ANL)
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 1006152
- Journal Information:
- J. Med. Chem., Journal Name: J. Med. Chem. Journal Issue: (11) ; 06, 2009 Vol. 52; ISSN JMCMAR; ISSN 0022-2623
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
Discovery and SAR of hydantoin TACE inhibitors
Journal Article
·
Thu Jul 23 00:00:00 EDT 2009
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1005728
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
Journal Article
·
Wed Jul 22 00:00:00 EDT 2009
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1007119
Discovery and SAR of hydantoin TACE inhibitors
Journal Article
·
Fri Sep 03 00:00:00 EDT 2010
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1002639